📖 Approx. 8 min
In the management of medical corporations, the fund system (kikin system) is a crucial mechanism unique to corporations without equity interest. Particularly when planning business succession or M&A, returning this fund involves intricate considerations regarding timing, procedural requirements, and tax treatment, demanding meticulous preparation. This article explores the multifaceted aspects of fund returns in medical corporations from an industry-specific perspective, offering practical insights to assist board chairpersons and clinic directors in making informed decisions.
What Is the Fund System in Medical Corporations? Relationship with Non-Equity Medical Corporations
Medical corporations in Japan are broadly classified by their incorporation structure into “medical corporations with equity interest” and “medical corporations without equity interest.” The fund system is a financing framework adopted by the latter, specifically by “fund-contributing medical corporations” (kikin-type medical corporations). Under this system, to secure the assets necessary for incorporation and ongoing operations, the entity receives contributions of cash or property in kind from designated contributors. Rather than issuing equity shares in exchange, the corporation commits to refunding the contributed amount in the future.
While medical corporations with equity interest are obligated to reimburse departing members (contributors) based on the appraised value of their equity interest upon withdrawal, fund-contributing medical corporations bear no such obligation. The fund functions essentially as a liability akin to a “loan with repayment obligations”; contributors acquire neither administrative ownership rights nor rights to claim residual assets upon dissolution. This structural distinction significantly impacts valuation methods and deal structuring during business succession and M&A transactions.
Although the fund plays a vital role in building corporate assets, its refund typically requires fulfilling conditions outlined in the articles of incorporation, securing approval at a general meeting of members, and submitting formal notifications to regulatory authorities. Understanding your medical corporation’s specific classification is the fundamental starting point for addressing fund return strategies.
Comparison: Medical Corporations with Equity Interest vs. Fund-Contributing Medical Corporations
| Item | Medical Corporation with Equity Interest | Fund-Contributing Medical Corporation |
|---|---|---|
| Primary Purpose | Envisions financial returns to equity contributors | Provision of medical care with high public interest |
| Legal Basis | Pre-reform Medical Care Act | Revised Medical Care Act (effective 2007) |
| Financing Method | Capital contributions from equity holders | Fund contributions from fund contributors |
| Members’ Rights | Right to residual asset distribution and refund claim upon withdrawal proportional to equity share | No residual asset distribution rights; no refund claim upon withdrawal (only claims for fund refund) |
| Inheritance | Equity interest is subject to inheritance tax | Fund refund claim is subject to inheritance tax (no equity interest exists) |
| Upon Corporate Dissolution | Residual assets are distributed according to equity share | Residual assets revert to the national treasury, etc. (after fund refund) |
* The comparison above illustrates general principles; actual details may vary depending on individual corporate articles of incorporation and specific circumstances.
Timing and Legal Requirements for Fund Returns
Because returning funds directly affects a medical corporation’s financial stability, it cannot be executed arbitrarily. Both statutory requirements and provisions in the articles of incorporation must be strictly observed.
First, a fund return must, in principle, follow the timing and conditions stipulated in the corporation’s articles of incorporation. In most instances, the articles specify that “funds may be returned following a resolution of the general meeting of members if, at the end of the fiscal year, the financial condition of the corporation is deemed sufficient to execute the return without impairing operations.” Being deemed “sufficient without impairment” concretely requires that the corporation’s net asset value does not fall below the total fund amount and that working capital remains adequate post-return.
Furthermore, given the highly public nature of medical corporations, creditor protection procedures may be required when refunding funds to safeguard creditors’ interests. This is necessary because returning funds diminishes corporate assets and may potentially compromise creditors’ claims. The required process generally mirrors capital reduction procedures under corporate law, involving public notices in the official gazette (Kanpo) and individual notifications to known creditors.
In business succession and M&A scenarios, it is common for funds contributed by the transferor (the current chairperson or related parties) to be returned after the succession is finalized. In such cases, to ensure stable management under the incoming leadership, strategic approaches such as scheduling the return several years out or implementing a phased return are often adopted. For larger successions that may influence regional healthcare delivery systems, alignment with the Regional Medical Care Vision must also be taken into consideration.
Because the legal conditions for fund returns involve nuances dictated both by the Medical Care Act and local prefectural supervisory policies, prior consultation with the competent supervisory authorities is essential.
Step-by-Step Procedures and Practical Considerations
Refunding a fund involves a multi-step process that demands thorough preparation. Procedures become considerably more intricate when succession involves restructuring corporate membership (replacing members of the general assembly).
✅ Standard Procedural Steps for Fund Returns
-
Review Articles of Incorporation & Convene General Meeting
Review the conditions for fund returns specified in the articles of incorporation (timing, procedures, approval bodies) and prepare to convene a general meeting of members. -
Approve Resolution for Fund Return
Adopt a formal resolution at the general meeting of members approving the fund return, explicitly defining the return amount, payment schedule, and method. If necessary, a resolution to amend the articles of incorporation is also passed. -
Execute Creditor Protection Procedures
If the return risks harming creditor interests, an objection period must be established through official gazette announcements and individual notices. The process moves forward once the period lapses without objections, or once settlement/collateral provision to creditors is completed. -
Regulatory Filings and Approval
File notifications or submit approval applications to the competent prefectural governor (or the Ministry of Health, Labour and Welfare) regarding amendments to the articles of incorporation and, where applicable, the fund return itself. This is critical for maintaining public trust and compliance. -
Execute Fund Disbursement
Following the completion of all statutory steps, funds are disbursed to the contributor. A final verification must be conducted to confirm that funding sources are sufficient and that corporate cash flow remains secure.
* Specific procedural requirements may vary based on corporate articles of incorporation, prefectural guidance, and the return amount.
A critical consideration is securing financial resources for the refund. A medical corporation’s financial health is subject to fluctuations driven by medical fee revisions and the ongoing costs of meeting facility standards; hence, fund return schedules must be crafted conservatively. If internal reserves are tight, securing bank loans may be considered; however, because this directly affects the entity’s financial soundness, decisions should be made prudently alongside specialized advisors.
Tax Treatment of Fund Returns
Fund returns entail specific tax implications for both the contributor and the medical corporation. Accurate comprehension and proper accounting treatment are essential.
From the contributor’s perspective, because the fund possesses the legal characteristics of a “loan with repayment obligations,” the return of the original contributed capital does not trigger income tax or corporate tax liabilities. This follows the general principle governing loans, where principal repayments are non-taxable events. This contrasts sharply with medical corporations with equity interest, where equity transfers or retirement buyouts are subject to capital gains taxation.
From the medical corporation’s perspective, the fund return itself does not affect the profit and loss statement; it merely reduces liabilities (funds) on the balance sheet. Consequently, it generates no direct corporate income tax or local enterprise tax liabilities. However, accumulating corporate profits to build sufficient refund reserves will incur standard corporate income taxes. Furthermore, if a refund transaction is structured improperly or construed as granting an economic benefit—such as disguising executive remuneration as a fund return—tax authorities may challenge the transaction during an audit.
Regarding Japanese Consumption Tax (JCT), both the contribution and the refund of funds are transactions without consideration, qualifying as non-taxable transactions exempt from consumption tax.
💡 Key Tax Points Regarding Fund Returns
- Contributor: If the returned amount matches the original contribution, it is generally exempt from income and corporate taxes.
- Medical Corporation: Because the transaction does not affect P&L, it generates no direct corporate or enterprise taxes.
- Consumption Tax: Classified as non-taxable transactions outside the scope of consumption tax.
- Risk Factor: Any irregular transactions deemed as disguised economic benefits will face scrutiny during tax audits.
* For specific tax assessments, always consult a licensed tax accountant or qualified professional.
To avoid confounding this process with capital gains taxation, stakeholders must share a unified and precise understanding of the tax position of fund returns.
Strategic Utilization of Fund Returns in Healthcare Succession
In medical corporation business succession and M&A, fund returns are not merely an administrative procedure, but a strategic lever that can make or break the transaction structure. Specifically, deciding how to handle funds contributed by the departing chairperson directly affects valuation adjustments, the successor entity’s post-closing financial health, and the smooth transition of governance.
For example, a common structure involves the buyer (successor) contributing new funds into the corporation, which the corporation then uses to return the original fund to the seller (current chairperson). In this scenario, the buyer contributes capital rather than acquiring equity shares; since this fund may be refunded in the future, it offers a distinct financial profile regarding capital recovery compared to equity acquisitions.
Additionally, the timing of fund returns must align closely with post-succession business plans. If major capital expenditures are anticipated—such as facility expansions, medical fee schedule changes, or meeting new facility accreditation standards—accelerating fund returns could deplete working capital and jeopardize operational stability. Formulating a sustainable return schedule backed by multi-year cash flow projections is paramount.
Preserving licensing and permit continuity is equally critical. Fund return procedures accompanied by changes in medical corporation representatives, board directors, or articles of incorporation require regulatory filings and prefectural approvals. Completing these formalities without delay ensures seamless administrative continuity. Any procedural oversight risks administrative sanctions, up to permit revocation or business suspension, demanding rigorous compliance management.
Executing fund returns in medical corporations requires comprehensive evaluation across accounting, tax, legal, and operational perspectives. Navigating these requirements effectively demands specialized expertise and proven execution experience.
Given its complexity, professional guidance is indispensable when managing fund returns for medical corporations. At M&A Medical, our seasoned specialists assist medical corporations through business succession and M&A, providing tailored advice on strategic timing, procedural execution, and tax considerations. Contact us today for a free consultation to identify the optimal solution for your clinic or hospital.
Consult M&A Medical for Healthcare Business Succession
M&A Medical is a specialized advisory firm dedicated to medical institution M&A and business succession. As an SME Agency-certified M&A support institution, we offer contingency-fee-based advisory services covering everything from the transfer of clinics and medical corporations facing successor shortages to strategic acquisitions.
- Free initial consultation and preliminary valuation
- Zero retainer and zero monthly fees (Success-fee only)
- Strict confidentiality guaranteed (Under non-disclosure agreement)
- Nationwide coverage across all 47 prefectures and all medical specialties
Whether you want to understand market valuations, address succession challenges, or explore group integration, we invite you to consult us at the earliest stage of your planning.